38 Years of Experience
Affiliated with a Castle Connolly Top Hospital
Who is Dr. Longo, Neurologist in Stanford, CA?
Dr. Frank Longo, MD, PHD is a Neurologist, who primarily practices in Stanford, CA. He has been practicing for over 38 years. Dr. Longo graduated from University of California and completed his residency at University Of California San Francisco. Dr. Longo is fluent in English, and is currently seeing new patients. Dr. Longo’s practice accepts Medicare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Longo’s office at (650) 723-4000.
Where did Dr. Longo go to medical school and complete their residency?
Residency: University Of California San Francisco
Medical School: University of California
What languages does Dr. Longo speak?
Dr. Longo and their clinical team can communicate with patients in the following languages:
English
What conditions does a Neurologist like Dr. Longo typically treat?
As a Neurologist, Dr. Longo diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Longo. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology.
Also known as:
- Mild Cognitive Impairment
- MCI
- Early Memory Loss
- Pre-Dementia
ICD-10 Codes:
- G3184: Mild cognitive impairment of uncertain or unknown etiology
Also known as:
- Alzheimer's Disease
- Alzheimer's Disease Fact Sheet
- AD
- Alzheimer's Dementia
- Memory Loss Disease
ICD-10 Codes:
- G309: Alzheimer's disease, unspecified
What procedures does a Neurologist like Dr. Longo typically perform?
As a Neurologist, procedures performed by Dr. Frank Longo may include:
- Aging Brain (Neuropsychological Testing)
- Cortical Basal Ganglionic Degeneration (CBGD)
- Deep Brain Stimulation
- Disturbance of Skin Sensation
- Electroencephalogram (EEG)
- Evoked Potential Testing
- Gait Simulation
- Greater Occipital Nerve (GON) Block
Please contact Dr. Longo's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.
Does Dr. Longo accept my insurance?
Dr. Longo accepts most major insurance plans. Important: Please call our office at (650) 723-4000 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Longo accept in Stanford, CA?
Dr. Longo in Stanford, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
Medicare
View All Insurances
Where is Dr. Longo's office located?
Recognitions
Publications
A Small Molecule TrkB Ligand Reduces Motor Impairment and Neuropathology in R6
, 2013
A Small Molecule p75(NTR) Ligand Protects Neurogenesis After Traumatic Brain Injury
, 2013
A small molecule p75
, 2013
Small-molecule modulation of neurotrophin receptors
, 2013
Oral Administration of a Small Molecule Targeted to Block proNGF Binding to p75 Promotes Myelin
, 2013
Optimizing the use of CROs by academia and small companies.
, 2013
Delayed Administration of a Small Molecule Tropomyosin-Related Kise B Lig
, 2012
Suppression of Immunodeficiency Virus
, 2012
Thy1-hAPP(Lond/Swe+)
, 2012
A TrkB Small Molecule Partial Agonist Rescues TrkB Phosphorylation Deficits
, 2012
Leukocyte Common Antigen
, 2011
LAR IS A FUNCTIOL RECEPTOR FOR CSPG AXON GROWTH INHIBITORS
, 2011
The p75 neurotrophin receptor is expressed by adult mouse dentate progenitor cells
, 2010
Small molecule BDNF mimetics activate TrkB sigling and prevent neurol degeneration in rodents
, 2010
The p75 Neurotrophin Receptor Promotes Amyloid-beta
, 2009
Sigling Through Rho GTPase Pathway as Viable Drug Target
, 2009
Small Molecule, Non-Peptide p75(NTR) Ligands Inhibit A beta
, 2008
A common motif targets huntingtin and the androgen receptor to the proteasome
, 2008
Anti-cancer drug induced neurotoxicity
, 2008
Small Molecule Modulation of p75 Neurotrophin Receptor Functions
, 2008
E-cadherin promotes retil ganglion cell neurite outgrowth in a protein tyrosine phosphatase
, 2007
Small molecule neurotrophin receptor ligands
, 2007
LAR protein tyrosine phosphatase receptor associates with TrkB
, 2006
Modulation of p75(NTR)
, 2006
Protein-tyrosine phosphatase
, 2006
Small, nonpeptide p75(NTR) ligands induce survival sigling and inhibit proNGF-induced death
, 2006
Downregulation of the LAR protein tyrosine phosphatase receptor is associated with increased
, 2006
Small molecule approaches for promoting neurogenesis.
, 2006
Identification of an ectodomain within the LAR protein tyrosine phosphat
, 2005
Neurotrophin receptor-based strategies for Alzheimer's disease.
, 2005
Neurotrophin Small Molecule Mimetics: Candidate Therapeutic Agents for Neurological Disorders
, 2005
Neurotrophin-based strategies for neuroprotection
, 2004
Neuroprotective strategies in Alzheimer's disease.
, 2004
A candidate chimeric mammalian mR transcript is derived from distinct chromosomes and is
, 2003
Leukocyte antigen-related protein tyrosine phosphatase receptor
, 2003
Alzheimer's therapeutics - Neurotrophin domain small molecule mimetics
, 2003
Modulation of Alzheimer-like syptic
, 2002
ProNGF induces p75-mediated death of oligodendrocytes following spil cord injury
, 2002
Alzheimer's therapeutics - Neurotrophin small molecule mimetics
, 2002
Alzheimer's therapeutics: Neurotrophin small molecule mimetics
, 2002
Psychological impact of news of genetic risk for Huntington disease
, 2001
The leukocyte common antigen
, 2001
Stress induces zinc finger immediate early genes in the rat adrel gland
, 2000
Nerve growth factor
, 2000
Downregulation of LAR tyrosine phosphatase prevents apoptosis
, 2000
Leukocyte common-antigen-related tyrosine phosphatase receptor
, 2000
Neurotrophin small-molecule mimetics
, 2000
Gene expression along the cerebral-spil axis after regiol gene delivery
, 1999
Leukocyte common antigen-related tyrosine phosphatase receptor
, 1999
Electromagnetic fields influence NGF activity and levels following sciatic nerve transection
, 1999
LAR tyrosine phosphatase receptor
, 1998
LAR tyrosine phosphatase receptor
, 1998
LAR Tyrosine Phosphatase Receptor
, 1998
Absence of p75(NTR) causes increased basal forebrain cholinergic neuron size
, 1997
Trinucleotide repeats in transgenic mice: New insights
, 1997
Aldose reductase inhibition increases CNTF-like bioactivity
, 1997
Synthetic NGF peptide derivatives prevent neurol death via a p75 receptor-dependent mechanism
, 1997
Deficient LAR expression decreases basal forebrain cholinergic neurol size
, 1997
Minimized hormones grow in stature
, 1996
CLONING OF RAT GRP75, AN HSP70-FAMILY MEMBER, AND ITS EXPRESSION IN NORMAL AND ISCHEMIC BRAIN
, 1995
LAR TYROSINE PHOSPHATASE RECEPTOR - ALTERTIVE SPLICING IS PREFERENTIAL TO THE NERVOUS-SYSTEM
, 1995
WILL CILIARY NEUROTROPHIC FACTOR SLOW PROGRESSION OF MOTOR-NEURON DISEASE
, 1994
LEUKOCYTE COMMON ANTIGEN-RELATED RECEPTOR
, 1993
INDUCTION OF GLUCOSE-REGULATED PROTEIN (GRP78) AND INDUCIBLE HEAT
, 1993
CD CLONING AND EXPRESSION OF STRESS-INDUCIBLE RAT HSP70 IN NORMAL AND INJURED RAT-BRAIN
, 1993
PROLONGED INCREASES IN NEUROTROPHIC ACTIVITY ASSOCIATED WITH KAITE
, 1993
HEAT-SHOCK PROTEINS USED TO SHOW THAT HALOPERIDOL PREVENTS NEUROL INJURY PRODUCED BY KETAMINE
, 1993
HALOPERIDOL PREVENTS INDUCTION OF THE HSP70 HEAT-SHOCK GENE IN NEURONS INJURED BY PHENCYCLIDINE
, 1992
TROPHIC ACTIONS OF RECOMBINT HUMAN NERVE GROWTH-FACTOR ON CULTURED RAT EMBRYONIC CNS CELLS
, 1990
DIRECT SEQUENCING OF PCR PRODUCTS USING THE MAXAM-GILBERT METHOD
, 1990
NERVE GROWTH-FACTOR INDUCES GENE
, 1990
THE INVITRO BIOLOGICAL EFFECT OF NERVE GROWTH-FACTOR IS INHIBITED BY SYNTHETIC PEPTIDES
, 1990
DEVELOPMENTAL REGULATION OF NERVE GROWTH-FACTOR AND ITS RECEPTOR IN THE RAT CAUDATE PUTAMEN
, 1989
NERVE REGENERATION THROUGH ARTIFICIAL TUBULAR IMPLANTS
, 1989
WHITE MATTER DISEASE IN AIDS - FINDINGS AT MR IMAGING
, 1988
DELAYED NERVE REGENERATION IN STREPTOZOTOCIN DIABETIC RATS
, 1986
ABNORMAL NERVE REGENERATION IN GALACTOSE NEUROPATHY
, 1986
NEURONOTROPHIC ACTIVITIES IN CEREBROSPIL-FLUID OF HEAD TRAUMA PATIENTS
, 1984
NEURITE-PROMOTING FACTORS AND EXTRACELLULAR
, 1984
NEURONOTROPHIC ACTIVITIES ACCUMULATE INVIVO WITHIN SILICONE NERVE REGENERATION CHAMBERS
, 1983
SPATIAL-TEMPORAL PROGRESS OF PERIPHERAL
, 1983
TEMPORAL CHANGES OF NEURONOTROPHIC ACTIVITIES ACCUMULATING INVIVO WITHIN NERVE REGENERATION
, 1983
ENDOGENOUS AND EXOGENOUS FACTORS SUPPORT NEUROL SURVIVAL AND CHOLINE
, 1983
LAMININ PROMOTES NEURITIC REGENERATION FROM CULTURED PERIPHERAL AND CENTRAL NEURONS
, 1983
NEURONOTROPHIC ACTIVITY IN BRAIN WOUNDS OF THE DEVELOPING RAT
, 1983
Spil cord neuronotrophic factors (SCNTFs): I. Bioassay of schwannoma and other conditioned media.
, 1982
INVIVO REGENERATION OF CUT NERVES ENCASED IN SILICONE TUBES - GROWTH ACROSS A 6-MILLIMETER GAP
, 1982
NERVE REGENERATION IN SILICONE CHAMBERS - INFLUENCE OF GAP LENGTH AND OF DISTAL STUMP COMPONENTS
, 1982
Growth factors and motor neurons.
, 1982
BRAIN INJURY CAUSES A TIME-DEPENDENT INCREASE IN NEURONOTROPHIC ACTIVITY AT THE LESION SITE
, 1982
NERVE REGENERATION MODEL AND TROPHIC FACTORS INVIVO
, 1982
COMPARATIVE FEATURES OF SPIL NEURONOTROPHIC FACTORS IN FLUIDS COLLECTED INVITRO AND INVIVO
, 1982
NERVE REGENERATION ACROSS AN EXTENDED GAP
, 1982
SPIL-CORD NEURONOTROPHIC FACTORS (SCNTFS) .1. BIOASSAY OF SCHWANNOMA AND OTHER CONDITIONED MEDIA
, 1982
RELATION OF SOMAL LIPID-SYNTHESIS TO THE FAST AXOL-TRANSPORT OF PROTEIN AND LIPID
, 1980
What is Dr. Longo's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Longo's National Provider Identifier (NPI) number is 1801966254.
What common questions do patients ask about Dr. Longo?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Longo
What is Dr. Frank Longo's specialty?
Dr. Longo is a Neurologist near Stanford, CA.
What does a Neurologist do?
A neuropathologist is expert in the diagnosis of diseases of the nervous system and skeletal muscles and functions as a consultant primarily to neurologists and neurosurgeons. The neuropathologist is knowledgeable in the infirmities of humans as they affect the nervous and neuromuscular systems, be they degenerative, infectious, metabolic, immunologic, neoplastic, vascular or physical in nature.